Lactic Acid

Lactic Acid

SCHEMBL367992

CC(O)C(=O)O.O=S(=O)(O)O.[AlH3].[AlH3].[NaH]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.65
CA5A P35218 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
TSHR P16473 1/20 0.35
KDM4E B2RXH2 1/20 0.33
GMNN O75496 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
PMP22 Q01453 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SLC7A5 Q01650 1/20 0.33
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lactic Acid SCHEMBL2671202 1.00 TP53 (0.65) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL5611216 0.94 TP53 (0.65) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL2329719 0.94 TP53 (0.73) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL28292938 0.91 TP53 (0.69) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL17181727 0.91 TP53 (0.69) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL28286519 0.91 TP53 (0.69) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL8948925 0.91 TP53 (0.69) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL1584321 0.91 TP53 (0.69) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL6394823 0.91 TP53 (0.69) TP53CA5ACA5BTSHRKDM4E
Lactic Acid SCHEMBL27886196 0.91 TP53 (0.69) TP53CA5ACA5BTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1247055-A Face-care compsns. containing pigment and anti-sweat agent, and application of same composns. OREAL (FR) 2000-03-15 CN claimed
CN-1246327-A Cosmetic composite containing pigment, anti-sweat agent and partial cross-linked solid elastic organic polyorganosiloxane and use of the composite OREAL (FR) 2000-03-08 CN claimed
EP-3801734-A1 METHODS FOR PROMOTING HAIR GROWTH Follica, Inc. (US) 2021-04-14 EP disclosed
EP-2648676-A1 METHODS FOR TREATING BALDNESS AND PROMOTING HAIR GROWTH Follica, Inc. (US) 2013-10-16 EP disclosed
US-8354096-B2 Water-free antiperspirant sprays with improved substance HENKEL AG & CO. KGAA (DE) 2013-01-15 US disclosed
WO-2012078649-A1 METHODS FOR TREATING BALDNESS AND PROMOTING HAIR GROWTH FOLLICA, INC. (US) 2012-06-14 WO disclosed
US-20120020906-A1 ANTIPERSPIRANT SPRAYS WITH ESTER OILS HENKEL AG & CO. KGAA (DE) 2012-01-26 US disclosed
US-20120014897-A1 WATER-FREE ANTIPERSPIRANT SPRAYS WITH IMPROVED SUBSTANCE RELEASE HENKEL AG & CO. KGAA (DE) 2012-01-19 US disclosed
US-20100260698-A1 Anhydrous Antiperspirant Compositions with Improved Active Substance Release HENKEL AG & CO. KGAA (DE) 2010-10-14 US disclosed
CN-101610814-A Low residue antiperspirant stick HENKEL KGAA (DE) 2009-12-23 CN disclosed
US-20090220444-A1 Antiperspirant and Deodorant Compositions with Improved Protective Action HENKEL AG & CO. KGAA (DE) 2009-09-03 US disclosed
WO-2004006883-A1 SKIN CARE COSMETIC COMPOSITIONS CONTAINING CARBOXYALKYLATES OF BRANCHED ALCOHOLS AND/OR ALKOXYLATES THEREOF UNILEVER PLC (GB) 2004-01-22 WO disclosed
CN-1247055-A Face-care compsns. containing pigment and anti-sweat agent, and application of same composns. OREAL (FR) 2000-03-15 CN disclosed
CN-1246327-A Cosmetic composite containing pigment, anti-sweat agent and partial cross-linked solid elastic organic polyorganosiloxane and use of the composite OREAL (FR) 2000-03-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120020906-A1 ANTIPERSPIRANT SPRAYS WITH ESTER OILS CUTA, NAPEPLD, LIPE TP53 3351/4885CA5A 4501/4885CA5B 4740/4885
US-20100260698-A1 Anhydrous Antiperspirant Compositions with Improved Active Substance Release CUTA, CYP2W1, IDUA TP53 4430/4885CA5A 3560/4885CA5B 4210/4885
US-20120014897-A1 WATER-FREE ANTIPERSPIRANT SPRAYS WITH IMPROVED SUBSTANCE RELEASE POLR1C, CTRL, CUTA TP53 1876/4885CA5A 4616/4885CA5B 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.